CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.12%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.78B
AUM Growth
+$56.1M
(+0.98%)
Cap. Flow
-$211M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
798
New
72
Increased
310
Reduced
286
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
+$28M |
| 2 |
Meta Platforms (Facebook)
META
|
+$25.9M |
| 3 |
Southwest Airlines
LUV
|
+$18.5M |
| 4 |
Travelers Companies
TRV
|
+$17.6M |
| 5 |
Cigna
CI
|
+$16.9M |
Top Sells
| 1 |
Biogen
BIIB
|
+$75.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$27.9M |
| 3 |
Gilead Sciences
GILD
|
+$25M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$22.7M |
| 5 |
Amazon
AMZN
|
+$21.4M |
Sector Composition
| 1 | Healthcare | 22.62% |
| 2 | Technology | 14.66% |
| 3 | Financials | 14.55% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Ametek
AME
$43.6B
| $3.57M | 0.06% |
49,192
+6,644
| +16% | +$481K |
|
327
BCE
BCE
$22.7B
| $3.55M | 0.06% |
73,746
+1,227
| +2% | +$59.1K |
|
328
Edwards Lifesciences
EW
$47.1B
| $3.52M | 0.06% |
93,549
-972
| -1% | -$36.5K |
|
329
Sysco
SYY
$39B
| $3.51M | 0.06% |
57,844
-8,155
| -12% | -$495K |
|
330
HP
HPQ
$27.4B
| $3.5M | 0.06% |
166,494
-3,011
| -2% | -$63.3K |
|
331
First Solar
FSLR
$21.8B
| $3.47M | 0.06% |
+51,405
| New | +$3.47M |
|
|
PARA
332
DELISTED
Paramount Global Class B
PARA
| $3.46M | 0.06% |
58,705
+29,704
| +102% | +$1.75M |
|
333
Ultragenyx Pharmaceutical
RARE
$3.04B
| $3.43M | 0.06% |
74,000
+14,000
| +23% | +$649K |
|
334
Deere & Co
DE
$130B
| $3.39M | 0.06% |
21,677
+1,906
| +10% | +$298K |
|
335
Ovintiv
OVV
$10.6B
| $3.39M | 0.06% |
50,598
-9,640
| -16% | -$645K |
|
336
Truist Financial
TFC
$59.3B
| $3.36M | 0.06% |
67,578
-3,027
| -4% | -$151K |
|
|
WP
337
DELISTED
Worldpay, Inc.
WP
| $3.36M | 0.06% |
+45,672
| New | +$3.36M |
|
338
Northern Trust
NTRS
$24.3B
| $3.36M | 0.06% |
33,602
+1,172
| +4% | +$117K |
|
339
Southern Company
SO
$99.9B
| $3.33M | 0.06% |
69,317
+1,866
| +3% | +$89.7K |
|
|
BPMC
340
DELISTED
Blueprint Medicines
BPMC
| $3.32M | 0.06% |
+44,000
| New | +$3.32M |
|
341
General Mills
GIS
$26.8B
| $3.31M | 0.06% |
55,765
+1,526
| +3% | +$90.5K |
|
342
Aflac
AFL
$56.9B
| $3.3M | 0.06% |
75,262
-108,596
| -59% | -$4.77M |
|
343
Manulife Financial
MFC
$52.2B
| $3.28M | 0.06% |
156,883
-1,605
| -1% | -$33.6K |
|
344
Enbridge
ENB
$105B
| $3.26M | 0.06% |
83,191
+8,821
| +12% | +$346K |
|
345
Bank of Montreal
BMO
$90.9B
| $3.25M | 0.06% |
40,463
+6,854
| +20% | +$550K |
|
346
Ecolab
ECL
$78.1B
| $3.25M | 0.06% |
24,201
-611
| -2% | -$82K |
|
347
Xcel Energy
XEL
$42.4B
| $3.23M | 0.06% |
67,170
+9,877
| +17% | +$475K |
|
348
Macy's
M
$4.57B
| $3.2M | 0.06% |
127,201
-538,075
| -81% | -$13.6M |
|
349
Crown Castle
CCI
$40.9B
| $3.2M | 0.06% |
28,797
+1,206
| +4% | +$134K |
|
350
Oneok
OKE
$44.9B
| $3.19M | 0.06% |
59,710
+14,777
| +33% | +$790K |
|